Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
WATCH: The challenge of protecting patents and innovation - obviousness-type double patenting post In re Cellect
Americas
WATCH: The challenge of protecting patents and innovation - obviousness-type double patenting post In re Cellect
Speakers from Acuitas Therapeutics, Thermo Fisher Scientific, Element Biosciences, and Cooley examine the risks and implications of obviousness-type double patenting and offer guidance for mitigating its impact on innovation.   15 December 2024
Foley & Lardner adds litigation and transaction expert in New York
Americas
Foley & Lardner adds litigation and transaction expert in New York
Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings nearly two decades of experience in IP strategy, litigation, and transactions | Experience in biotechnology, medical devices, and blockchain.   12 December 2024
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
Europe
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
Paris Local Division revokes Dexcom patent and dismisses infringement action against rival | UPC revoked two other patents belonging to medical device company earlier in 2024.   12 December 2024
Americas
‘A marathon and a sprint at the same time’: How we won $452m damages
With 27 witnesses, plus both patent infringement and misappropriation claims, lead counsel for Insulet Alexandra Valenti and Scott Bluni share ‘a milestone’ in DTSA case law.   12 December 2024
Americas
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
BlueAllele “plausibly alleged” that some of Intellia’s uses of technology were not reasonably related to FDA approval | Biotech claimed competitor received over $100m from Regeneron for using innovation to research therapeutic candidates.   10 December 2024
Americas
‘AI curious’ counsel at AZ, Novartis weigh risks and benefits
Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading pharma counsel.   10 December 2024
Americas
Trump’s return sparks calls for pro-patent agenda
As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen.   5 December 2024
Americas
EOFlow ordered to pay rival $452m over insulin patch trade secrets
Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.   5 December 2024
Americas
WATCH: Korean biopharma's global expansion - evolving patent strategies and regulatory landscape
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past.   4 December 2024
Americas
WATCH: European patent term extension (SPCs)
Speakers from Kilburn & Strode discuss key differences between European SPCs and US PTEs, outlining strategies for maximising protection for pharmaceutical and biologic products in Europe.   4 December 2024